Stocks and Investing
Stocks and Investing
Thu, May 9, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Raghuram Selvaraju Reiterated (AQST) at Strong Buy and Held Target at $9 on, May 9th, 2024
Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aquestive Therapeutics, Inc." (AQST) at Strong Buy and Held Target at $9 on, May 9th, 2024.
Raghuram has made no other calls on AQST in the last 4 months.
There are 5 other peers that have a rating on AQST. Out of the 5 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 5 analyists that currently disagree with Raghuram
- David Amsellem of "Piper Sandler" Initiated at Buy and Held Target at $10 on, Thursday, April 11th, 2024
- Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $7 on, Thursday, March 28th, 2024
- Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $10 on, Friday, March 15th, 2024
- Thomas Flaten of "Lake Street" Maintained at Strong Buy with Increased Target to $8 on, Thursday, March 7th, 2024
- Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $9 on, Thursday, March 7th, 2024
Contributing Sources